Teradyne, Inc. (FRA:TEY)

CTI BioPharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	14,472	19,808	15,009	12,730	23,439	16,275
Market Cap Growth	-23.17%	31.97%	17.90%	-45.69%	44.02%	59.83%
Enterprise Value	14,113	19,230	14,367	12,026	22,352	15,562
Last Close Price	92.04	121.27	97.88	80.13	143.27	95.19
PE Ratio	36.14	37.81	36.97	19.02	26.27	25.39
PS Ratio	6.00	7.27	6.20	4.31	7.20	6.38
PB Ratio	5.98	7.27	6.57	5.55	10.40	9.02
P/TBV Ratio	7.51	8.52	8.00	6.82	12.94	12.05
P/FCF Ratio	29.81	43.26	38.98	32.81	27.60	29.11
P/OCF Ratio	21.39	30.51	28.35	23.54	24.27	22.91
EV/Sales Ratio	5.76	7.06	5.93	4.07	6.87	6.10
EV/EBITDA Ratio	23.69	29.82	25.32	12.75	19.05	18.59
EV/EBIT Ratio	31.30	36.33	30.76	14.32	21.03	21.22
EV/FCF Ratio	29.07	42.00	37.32	30.99	26.32	27.83
Debt / Equity Ratio	0.03	0.03	0.03	0.05	0.07	0.21
Debt / EBITDA Ratio	0.09	0.11	0.12	0.13	0.13	0.44
Debt / FCF Ratio	0.11	0.16	0.19	0.32	0.19	0.69
Asset Turnover	0.82	0.78	0.77	0.86	0.99	0.97
Inventory Turnover	3.58	3.85	3.59	4.53	6.43	6.38
Quick Ratio	1.49	1.72	1.88	1.86	2.38	2.76
Current Ratio	2.71	2.91	3.28	3.03	3.20	3.45
Return on Equity (ROE)	21.55%	20.29%	18.03%	28.54%	42.55%	42.53%
Return on Assets (ROA)	10.56%	9.52%	9.23%	15.35%	20.25%	17.42%
Return on Capital (ROIC)	13.65%	12.44%	12.43%	21.05%	27.85%	24.27%
Return on Capital Employed (ROCE)	19.70%	17.80%	18.30%	32.60%	40.20%	30.40%
Earnings Yield	2.77%	2.65%	2.71%	5.26%	3.81%	3.94%
FCF Yield	3.36%	2.31%	2.56%	3.05%	3.62%	3.44%
Dividend Yield	0.47%	0.38%	0.41%	0.51%	0.25%	0.34%
Payout Ratio	16.55%	14.09%	15.13%	9.74%	6.50%	8.48%
Buyback Yield / Dilution	0.05%	0.60%	3.20%	7.56%	-0.32%	-2.00%
Total Shareholder Return	0.52%	0.98%	3.61%	8.08%	-0.07%	-1.65%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.